Osada T - Search Results

1

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.

Xia W, Petricoin EF 3rd, Zhao S, Liu L, Osada T, Cheng Q, Wulfkuhle JD, Gwin WR, Yang X, Gallagher RI, Bacus S, Lyerly HK, Spector NL. Xia W, et al. Among authors: osada t. Breast Cancer Res. 2013;15(5):R85. doi: 10.1186/bcr3480. Breast Cancer Res. 2013. PMID: 24044505 Free PMC article.

2

Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.

Osada T, Morse MA, Lyerly HK, Clay TM. Osada T, et al. Int Immunol. 2005 Sep;17(9):1143-55. doi: 10.1093/intimm/dxh292. Epub 2005 Jul 18. Int Immunol. 2005. PMID: 16027139

3

NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity.

Osada T, Clay T, Hobeika A, Lyerly HK, Morse MA. Osada T, et al. Cancer Immunol Immunother. 2006 Sep;55(9):1122-31. doi: 10.1007/s00262-005-0089-3. Epub 2005 Nov 5. Cancer Immunol Immunother. 2006. PMID: 16273350 Free PMC article. Clinical Trial.

4

Role of natural killer cell function in dendritic cell-based vaccines.

Woo CY, Clay TM, Lyerly HK, Morse MA, Osada T. Woo CY, et al. Among authors: osada t. Expert Rev Vaccines. 2006 Feb;5(1):55-65. doi: 10.1586/14760584.5.1.55. Expert Rev Vaccines. 2006. PMID: 16451108 Free article. Review.

5

Recent clinical progress in virus-based therapies for cancer.

Woo CY, Osada T, Clay TM, Lyerly HK, Morse MA. Woo CY, et al. Among authors: osada t. Expert Opin Biol Ther. 2006 Nov;6(11):1123-34. doi: 10.1517/14712598.6.11.1123. Expert Opin Biol Ther. 2006. PMID: 17049011 Review.

6

Dendritic cell-based immunotherapy.

Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK. Osada T, et al. Int Rev Immunol. 2006 Sep-Dec;25(5-6):377-413. doi: 10.1080/08830180600992456. Int Rev Immunol. 2006. PMID: 17169781 Review.

7

Immunotherapeutic targeting of Wilms' tumor protein.

Hutchings Y, Osada T, Woo CY, Clay TM, Lyerly HK, Morse MA. Hutchings Y, et al. Among authors: osada t. Curr Opin Mol Ther. 2007 Feb;9(1):62-9. Curr Opin Mol Ther. 2007. PMID: 17330403 Review.

8

Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2.

Morse MA, Hobeika A, Osada T, Niedzwiecki D, Marcom PK, Blackwell KL, Anders C, Devi GR, Lyerly HK, Clay TM. Morse MA, et al. Among authors: osada t. J Transl Med. 2007 Sep 6;5:42. doi: 10.1186/1479-5876-5-42. J Transl Med. 2007. PMID: 17822557 Free PMC article. Clinical Trial.

9

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.

Osada T, Chong G, Tansik R, Hong T, Spector N, Kumar R, Hurwitz HI, Dev I, Nixon AB, Lyerly HK, Clay T, Morse MA. Osada T, et al. Cancer Immunol Immunother. 2008 Aug;57(8):1115-24. doi: 10.1007/s00262-007-0441-x. Epub 2008 Jan 10. Cancer Immunol Immunother. 2008. PMID: 18193223 Free PMC article.

10

Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.

Osada T, Woo CY, McKinney M, Yang XY, Lei G, Labreche HG, Hartman ZC, Niedzwiecki D, Chao N, Amalfitano A, Morse MA, Lyerly HK, Clay TM. Osada T, et al. Clin Cancer Res. 2009 Apr 15;15(8):2789-96. doi: 10.1158/1078-0432.CCR-08-2589. Epub 2009 Apr 7. Clin Cancer Res. 2009. PMID: 19351755 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

762 results

Search Page

Filters